Literature DB >> 7906095

Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression.

T Hirano1, B Franzén, H Kato, Y Ebihara, G Auer.   

Abstract

Squamous cell lung carcinomas (SCCs) represent a highly malignant group of tumors, and effective treatment is greatly dependent upon early diagnosis. However, objective diagnosis of atypia is difficult and useful markers need to be defined. In this study, genomic instability, cell proliferation, and cellular accumulation of mutant p53, as reflected by DNA aneuploidy, proliferating cell nuclear antigen, and p53 immunoreactivity, respectively, were evaluated in bronchial squamous metaplasia without atypia (n = 4), bronchial squamous metaplasia with low-grade atypia (n = 12), bronchial squamous metaplasia with high-grade atypia (n = 15), early-stage SCC (n = 15), and advanced-stage SCC (n = 33). Our results suggest that hyperproliferation is an early event followed by DNA aneuploidy, which in turn precedes p53 immunoreactivity in the genesis of SCC. We conclude that routine assessment of proliferating cell nuclear antigen, DNA ploidy, and p53 may be valuable for the early diagnosis of SCC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7906095      PMCID: PMC1887133     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

Review 1.  Determination of biomarkers for intermediate end points in chemoprevention trials.

Authors:  J S Lee; S M Lippman; W K Hong; J Y Ro; S Y Kim; R Lotan; W N Hittelman
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

Review 2.  Mutator phenotype may be required for multistage carcinogenesis.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  1991-06-15       Impact factor: 12.701

3.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

Review 4.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

Review 5.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

6.  p53 mutations occur in aggressive breast cancer.

Authors:  R Mazars; L Spinardi; M BenCheikh; J Simony-Lafontaine; P Jeanteur; C Theillet
Journal:  Cancer Res       Date:  1992-07-15       Impact factor: 12.701

7.  Identification of p53 gene mutations in bladder cancers and urine samples.

Authors:  D Sidransky; A Von Eschenbach; Y C Tsai; P Jones; I Summerhayes; F Marshall; M Paul; P Green; S R Hamilton; P Frost
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

8.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

9.  Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners.

Authors:  K H Vähäkangas; J M Samet; R A Metcalf; J A Welsh; W P Bennett; D P Lane; C C Harris
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  19 in total

Review 1.  Translating tissue-engineered tracheal replacement from bench to bedside.

Authors:  Madhuri Kalathur; Silvia Baiguera; Paolo Macchiarini
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

2.  Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators.

Authors:  Athamassios Kotsinas; Konstantinos Evangelou; Panayotis Zacharatos; Christos Kittas; Vassilis G Gorgoulis
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 3.  Pulmonary preinvasive neoplasia.

Authors:  K M Kerr
Journal:  J Clin Pathol       Date:  2001-04       Impact factor: 3.411

Review 4.  Stage-specific gene expression during hepatocarcinogenesis in the rat.

Authors:  H C Pitot
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  EGFR/erB-1, HER2/erB-2, CK7, LP34, Ki67 and P53 expression in preneoplastic lesions of bronchial epithelium: an immunohistochemical and genetic study.

Authors:  Vítor Sousa; Joana Espírito Santo; Maria Silva; Teresa Cabral; Ana Maria Alarcão; Ana Gomes; Patrícia Couceiro; Lina Carvalho
Journal:  Virchows Arch       Date:  2011-03-22       Impact factor: 4.064

6.  Inverted papilloma of the urinary bladder: a case evaluated for malignant potential.

Authors:  S Urakami; M Igawa; H Shirakawa; H Shiina; T Ishibe
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

7.  DNA-PKc deficiency drives pre-malignant transformation by reducing DNA repair capacity in concert with reprogramming the epigenome in human bronchial epithelial cells.

Authors:  Ivo Teneng; Maria A Picchi; Shuguang Leng; Christopher P Dagucon; Suresh Ramalingam; Carmen S Tellez; Steven A Belinsky
Journal:  DNA Repair (Amst)       Date:  2019-04-27

8.  Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.

Authors:  H Kitamura; Y Kameda; N Nakamura; Y Nakatani; Y Inayama; M Iida; K Noda; N Ogawa; T Shibagaki; M Kanisawa
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

9.  Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers.

Authors:  M F Melhem; J C Law; L el-Ashmawy; J T Johnson; R J Landreneau; S Srivastava; T L Whiteside
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

10.  Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer.

Authors:  Marileila Varella-Garcia; Lin Chen; Roger L Powell; Fred R Hirsch; Timothy C Kennedy; Robert Keith; York E Miller; John D Mitchell; Wilbur A Franklin
Journal:  Am J Respir Crit Care Med       Date:  2007-06-28       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.